Adjuvant Therapy for Gallbladder Carcinoma: The Mayo Clinic Experience

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 1, 2009, Pages 150-155

  Gold, Douglas G ^a   Miller, Robert C ^a   Haddock, Michael G ^a   Gunderson, Leonard L ^b   Quevedo, Fernando ^a   Donohue, John H ^a   Bhatia, Sumita ^a   Nagorney, David M ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Adjuvant therapy; Chemotherapy; Gallbladder carcinoma; Radiotherapy

Indexed keywords

5-FLUOROURACIL; ADJUVANT THERAPY; ADJUVANT TREATMENT; CHEMORADIOTHERAPY; CONFIDENCE INTERVAL; COX MODEL; GALLBLADDER CANCER; GALLBLADDER CARCINOMA; HAZARD RATIO; OVERALL SURVIVAL; PROGNOSTIC FACTORS; RANK TEST; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

CHEMOTHERAPY; RADIOTHERAPY;

BIOLOGICAL ORGANS;

FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BOLUS INJECTION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GALLBLADDER CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, ADENOSQUAMOUS; CHEMOTHERAPY, ADJUVANT; FEMALE; FLUOROURACIL; GALLBLADDER NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 67650298698     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.052     Document Type: Article

References (33)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Henson D.E., Albores-Saavedra J., and Corle D. Carcinoma of the gallbladder: histologic types, stage of disease, grade, and survival rates. Cancer 70 (1992) 1493-1497
3. Kresl J.J., Schild S.E., Henning G.T., et al. Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys 52 (2002) 167-175
4. Czito B.G., Hurwitz H.I., Clough R.W., et al. Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: A 23-year experience. Int J Radiat Oncol Biol Phys 62 (2005) 1030-1034
5. Pahlajani N.H., Ruth K.J., Freedman G.M., et al. Radiation therapy in gallbladder cancer treatment: The Fox Chase Cancer Center experience [Abstract]. Int J Radiat Oncol Biol Phys 69 Suppl. 1 (2007) S301
6. Baeza M.R., Reyes J.M., del Castillo C., et al. Post-operative adjuvant radiochemotherapy in the treatment of gallbladder cancer [Abstract]. Int J Radiat Oncol Biol Phys 63 Suppl. (2005) S285-S286
7. Greene F.L., Page D.L., Fleming I.D., et al., for the American Joint Committee on Cancer (AJCC). Cancer staging manual. 6th ed. (2002), Springer, New York
8. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
9. Cox D.R. Regression models and life-tables (with discussion). J R Stat Soc B 34 (1972) 187-220
10. Ogura Y., Mizumoto R., Isaji S., et al. Radical operations for carcinoma of the gallbladder: Present status in Japan. World J Surg 15 (1991) 337-343
11. Donohue J.H., Nagorney D.M., Grant C.S., et al. Carcinoma of the gallbladder: Does radical resection improve outcome?. Arch Surg 125 (1990) 237-241
12. de Aretxabala X.A., Roa I.S., Burgos L.A., et al. Curative resection in potentially resectable tumours of the gallbladder. Eur J Surg 163 (1997) 419-426
13. Shirai Y., Yoshida K., Tsukada K., et al. Inapparent carcinoma of the gallbladder: An appraisal of a radical second operation after simple cholecystectomy. Ann Surg 215 (1992) 326-331
14. Fong Y., Heffernan N., and Blumgart L.H. Gallbladder carcinoma discovered during laparoscopic cholecystectomy: Aggressive reresection is beneficial. Cancer 83 (1998) 423-427
15. Kopelson G., and Gunderson L.L. Primary and adjuvant radiation therapy in gallbladder and extrahepatic biliary tract carcinoma. J Clin Gastroenterol 5 (1983) 43-50
16. Boerma E.J. Towards an oncological resection of gall bladder cancer. Eur J Surg Oncol 20 (1994) 537-544
17. Shimada H., Endo I., Togo S., et al. The role of lymph node dissection in the treatment of gallbladder carcinoma. Cancer 79 (1997) 892-899
18. Ruckert J.C., Ruckert R.I., Gellert K., et al. Surgery for carcinoma of the gallbladder. Hepatogastroenterology 43 (1996) 527-533
19. Kalser M.H., and Ellenberg S.S. Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120 (1985) 899-903 Erratum Arch Surg 1986;121:1045
20. Macdonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 (2001) 725-730
21. Maibenco D.C., Smith J.L., Nava H.R., et al. Carcinoma of the gallbladder. Cancer Invest 16 (1998) 33-39
22. Kopelson G., Galdabini J., Warshaw A.L., et al. Patterns of failure after curative surgery for extra-hepatic biliary tract carcinoma: Implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 7 (1981) 413-417
23. Wang S.J., Fuller C.D., Kim J.S., et al. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol 26 (2008) 2112-2117
24. Houry S., Schlienger M., Huguier M., et al. Gallbladder carcinoma: Role of radiation therapy. Br J Surg 76 (1989) 448-450
25. Hanna S.S., and Rider W.D. Carcinoma of the gallbladder or extrahepatic bile ducts: The role of radiotherapy. Can Med Assoc J 118 (1978) 59-61
26. Mojica P., Smith D., and Ellenhorn J. Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease. J Surg Oncol 96 (2007) 8-13
27. Takada T., Amano H., Yasuda H., et al., for the Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95 (2002) 1685-1695
28. Kayahara M., and Nagakawa T. Recent trends of gallbladder cancer in Japan: An analysis of 4,770 patients. Cancer 110 (2007) 572-580
29. O'Connell M.J., Martenson J.A., Wieand H.S., et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331 (1994) 502-507
30. Jarnagin W.R., Ruo L., Little S.A., et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: Implications for adjuvant therapeutic strategies. Cancer 98 (2003) 1689-1700
31. McGinn C.J., Ten Haken R.K., Ensminger W.D., et al. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol 16 (1998) 2246-2252
32. Corsini M.M., Miller R.C., Haddock M.G., et al. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: The Mayo Clinic experience (1975-2005). J Clin Oncol 26 (2008) 3511-3516
33. Bhatia S., Miller R.C., Haddock M.G., et al. Adjuvant therapy for ampullary carcinomas: The Mayo Clinic experience. Int J Radiat Oncol Biol Phys 66 (2006) 514-519